Polypeptide-engineered DNA tetrahedrons for targeting treatment of colorectal cancer via apoptosis and autophagy.

@article{Zhang2019PolypeptideengineeredDT,
  title={Polypeptide-engineered DNA tetrahedrons for targeting treatment of colorectal cancer via apoptosis and autophagy.},
  author={Nan Zhang and Yanan Yang and Ziyi Wang and Jing Yang and Xiao Chu and Jin Liu and Yongxing Zhao},
  journal={Journal of controlled release : official journal of the Controlled Release Society},
  year={2019}
}
  • N. Zhang, Yanan Yang, Yongxing Zhao
  • Published 10 September 2019
  • Biology, Chemistry
  • Journal of controlled release : official journal of the Controlled Release Society
4 Citations
The role of cell‐penetrating peptides in potential anti‐cancer therapy
TLDR
The CPPs‐based drug delivery strategy could be improved by clever design or chemical modifications to develop the next‐generation CPP's with enhanced cell penetration capability, stability and selectivity.
DNA nanotechnology-facilitated ligand manipulation for targeted therapeutics and diagnostics.
Nanoscale FasL Organization on DNA Origami to Decipher Apoptosis Signal Activation in Cells.
TLDR
DNA origami-based nanoagents with nanometer precise arrangements of the death receptor ligand FasL are introduced and presented to cells, and they define molecular benchmarks in apoptosis signal initiation and constitute a new strategy to drive particular cell responses.
Improved cancer phototheranostic efficacy of hydrophobic IR780 via parenteral route by association with tetrahedral nanostructured DNA.
  • Shuo Wang, Zengyi Liu, Meng Meng
  • Biology, Chemistry
    Journal of controlled release : official journal of the Controlled Release Society
  • 2020

References

SHOWING 1-10 OF 31 REFERENCES
SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer
TLDR
DOX@TD-2F2S exhibited a synergic anticancer biological effect with chemotherapy and can be a promising strategy for treating colorectal cancer.
DNA Nanostructure‐Based Systems for Intelligent Delivery of Therapeutic Oligonucleotides
TLDR
This progress report describes how therapeutic oligonucleotides including unmethylated cytosine–phosphate–guanine dinucleotide oligos, small interfering RNA, single guide RNA of the regularly interspaced short palindromic repeat–Cas9 system, and aptamers, are successfully loaded on DNA nanostructures for delivery.
FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells
TLDR
FK-16 induces caspase-independent apoptosis and autophagy through the common p53-Bcl-2/Bax cascade in colon cancer cells and uncovered previously unknown reciprocal regulation between these two cell death pathways.
Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin.
  • Honglian Yu, Jiao Chen, Yong Hu
  • Biology, Chemistry
    Journal of controlled release : official journal of the Controlled Release Society
  • 2015
Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery
TLDR
It is shown that self-assembled DNA tetrahedral nanoparticles with a well-defined size can deliver siRNAs into cells and silence target genes in tumours and, gene silencing occurs only when the ligands are in the appropriate spatial orientation.
DNA Nanotechnology-Enabled Drug Delivery Systems.
TLDR
The origin of DNA nanotechnology is reviewed, followed by summarizing state-of-the-art strategies for the construction of DNAnanostructures and drug payloads delivered by DNA nanovehicles and challenges and opportunities for DNA nanostructure-based drug delivery.
Studies on anticancer activities of antimicrobial peptides.
Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
TLDR
Cationic liposomes can accommodate a wide range of different SLPs and are therefore a potential delivery platform for personalized cancer vaccines, indicating improved immunological activity of the SLPs.
...
...